To the question of creating conditions for determining the sterility of drugs in the microbiological laboratory
- Authors: Gunar O.V.1, Dorenskaya A.V.1, Votiakova V.S.1
-
Affiliations:
- Scientific Centre for Expert Evaluation of Medicinal Products
- Issue: Vol 69, No 4 (2020)
- Pages: 5-10
- Section: Articles
- URL: https://journals.eco-vector.com/0367-3014/article/view/113324
- DOI: https://doi.org/10.29296/25419218-2020-04-01
- ID: 113324
Cite item
Abstract
Correspondence of the quality of drugs in terms of «Sterility» guarantees the safety of the use of drugs for injection and infusion, eye drops and films, pharmaceutical substances and excipients, including biological drugs and their solvents, which must be sterile in accordance with regulatory documents and pharmacopeia articles. In the article, the authors consider the necessary conditions for the organization and conduct of the sterility test of drugs. The creation, operation and maintenance of the described conditions is in the area of responsibility of production, control and expert microbiological laboratories. Among the necessary conditions, the following are highlighted: a special aseptic room with a certain confirmed purity class; microbiological monitoring; proven sterility of all consumables, solutions and culture media used; test methods used with proven applicability. Actively discusses the issue that arises when a contaminated sample is detected. The revealed fact requires an investigation of the causes of the situation and a possible further recognition of the drug as poor in terms of «Sterility». The materials are included in the draft General Pharmacopoeia Monograph «Conditions for determining the sterility of drugs», which is currently under consideration and approval in the prescribed manner for further inclusion in the State Pharmacopoeia of the Russian Federation.
Keywords
Full Text
![Restricted Access](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
About the authors
Olga Viktorovna Gunar
Scientific Centre for Expert Evaluation of Medicinal Products
Email: gunar@expmed.ru
Head of Laboratory of Microbiology, Doctor of Pharmaceutical Sciences Moscow, 127051, Russian Federation
Anna Viktorovna Dorenskaya
Scientific Centre for Expert Evaluation of Medicinal Products
Email: dorenskaya@expmed.ru
Leading Expert of Laboratory of Microbiology Moscow, 127051, Russian Federation
Venera Shamilevna Votiakova
Scientific Centre for Expert Evaluation of Medicinal Products
Email: votiakovavs@expmed.ru
Labengineer of Laboratory of Microbiology Moscow, 127051, Russian Federation
References
- Государственная фармакопея Российской Федерации XIV изд. [Электронное издание] Режим доступа: https://femb.ru/ femb/pharmacopea.php
- Приказ Министерства промышленности и торговли от 14 июня 2013 г. №916 «Об утверждении Правил организации производства и контроля качества лекарственных средств».
- Sandle T. Designing and Implementing an Environmental Monitoring Program. Biocontamination Control for Pharmaceuticals and Healthcare, 2019. [Electronic resource]. Access mode: https:// www.sciencedirect.com/topics/medicine-and-dentistry/environmental-monitoring (circulation date 12.12.2019).
- Sandle T. Microbiology laboratory techniques. Pharmaceutical Microbiology, 2016. [Electronic resource]. Access mode: https:// www.sciencedirect.com/topics/medicine-and-dentistry/environmental-monitoring (circulation date 12/12/2019).
- Правила GMP - электронная система обучения. [Электронный ресурс]. Режим доступа: https://e-learning.favea.org/instructions/presentation (дата обращения 12.12.2019).
- European Pharmacopoeia Online.European Directorate for the Quality of Medicines, 2017. [Electronic resource]. Access mode: https://online.edqm.eu/ (circulation date 12/12/2019).
- Salaman-Byron A.L. Limitations of microbiological environmental monitoring methods in cleanrooms. Research & Development, 2018. [Electronic resource]. Access mode: https:// www.americanpharmaceuticalreview.com/Featured-Articles/349192-Limitations-of-Microbial-Environmental-Monitoring-Methods-in-Cleanrooms/ ( circulation date 12/12/2019).
- Sandle T. Viable Environmental Monitoring Methods. Biocontamination Control for Pharmaceuticals and Healthcare, 2019. [Electronic resource]. Access mode: https:// www.sciencedirect.com/ topics/medicine-and-dentistry/environmental-monitoring/ (circulation date 12/12/2019).
- United States Pharmacopoeia. Vol. 40<1113> Microbiological characterization, identification and typing of strains. Rockville, Maryland, USA. 2015.
- Riley B. Rapid Microbiology Methods in the Pharmaceutical Industry. American pharmaceutical review, 2006 [Electronic resource] Access mode: https://www.americanpharmaceuticalreview. com/Featured-Articles/113094-Rapid-Microbiology-Methods-in-the-Pharmaceutical-Industry/( circulation date 12/12/2019).
- Гунар О.В., Сахно Н.Г. Количественное определение микроорганизмов-контаминантов лекарственных средств с использованием системы «Milliflex® quantum». Фармация. 2019; 68 (3): 5-11.
- Dalmaso G., Denoya C. Qualification of environmental monitoring program.Technical marking, 2015. [Electronic resource]. Access mode: https:// www.americanpharmaceuticalreview.com/ Featured-Articles/349192-Limitations-of-Microbial-Environmental-Monitoring-Methods-in-Cleanrooms/ (circulation date 12/12/2019).
Supplementary files
![](/img/style/loading.gif)